Navigation Links
WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation
Date:11/14/2007

LA JOLLA, Calif., Nov. 14 /PRNewswire-FirstCall/ -- Stephen D. Ferrone, CEO of Immunosyn Corporation (OTC Bulletin Board: IMYN) will be featured in an exclusive interview with http://www.wallst.net scheduled for November 16 at 8:00 A.M. PST. The interview will be posted on http://www.wallst.net by 5 P.M. EST on November 16, 2007.

The interview will cover topics including Immunosyn's market potential, growth initiatives, competitive edge, recent news and milestones that investors should watch for.

"This interview is a part of our strategic market communication plan which includes meeting with brokers and institutional managers as well as taking part in interviews," says Stephen D. Ferrone, CEO and President of Immunosyn.

To hear the interview in its entirety, visit http://wallst.net and click on "Interviews." The interview can be accessed by locating the company's ticker symbol (IMYN) under the appropriate exchange (OTCBB) at the top of the "Interviews" section or by entering the company's ticker symbol (IMYN) in the Search Archive window.

About Immunosyn Corporation

La Jolla, CA-headquartered Immunosyn Corporation (IMYN.OTC.BB) plans to market and distribute life enhancing therapeutics. Currently, the company has exclusive worldwide rights from its largest shareholder, Argyll Biotechnologies, LLC, to market, sell and distribute SF-1019, a compound that was developed from extensive research into Biological Response Modifiers (BRMs). Argyll Biotechnologies, LLC has initiated the process for regulatory approval of SF-1019 in several countries and preparations for clinical trials are underway in both the US and Europe. Research suggests that SF-1019 has the potential to affect a number of clinical conditions including complications from Diabetic Mellitus such as Diabetic Neuropathy (DN) and
'/>"/>

SOURCE Immunosyn Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of Osteologix
2. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
3. WallSt.net Announces Upcoming Interview with CEO of BioSante Pharmaceuticals
4. WallSt.net Announces Upcoming Interview With CEO of Biomoda
5. Synvista Therapeutics to be Featured on Wallst.net
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , COPENHAGEN, Dec. 2 Th... with BioIsoprene technology, a breakthrough alter...dient in the manufacture of synthetic rubber with ... Denmark, this week. One tire will be on display a...enhagen International Airport throughout December ...
(Date:12/2/2009)..., , LIBREVILLE, Gabon, December 2 /PR... in Africa: Everyone,s Problem and Heritage" ,,...odiversity, 2-3 June 2010 the,Gabonese Republic is...,(Gabon) on the issue of safeguarding biological r...d by government and state leaders, ministers,scie...
(Date:12/2/2009)..., , JERUSALEM, Israel, December...easibility study evaluating the preclinical (anima...duct which combines technology from Weill,Cornell ...ave potential to,treat inherited anemias such as C...ng a series of technologies to expand, ex vivo,po...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewsw...e" or the "Company") (NYSE: SCR ), a leading pha...t, manufacturing, and marketing of branded,generic...nnounced that 105 of,its drugs have been included ..."), which was issued by China,s Ministry of Human ...
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
...ter With Patented Triple Arterial Lumen ... /PRNewswire-FirstCall/ - Angiotech Pharmaceutical...that it will introduce and,exhibit its innovative ...08,Society of Interventional Radiology (SIR) Annua...from March 15-18, 2008., "It,s exciting to partic...
...orporated,(Nasdaq: VPHM ) today announced that Vi...erating officer of ViroPharma, will present at the...e at 1:40 P.M. ET on Tuesday,March 18, 2008. The c...ley,Place., ViroPharma,s presentation will be web...arma.com and available through April 1, 2008., A...
...cs plc,(AIM: SLN) today announces a collaboration ...ment of a range of novel approaches for the delive...Therapeutics, leading,expertise in the delivery of...he functional systemic delivery of siRNA in vivo u...cial details of this,collaboration, in which both ...
Other Biology Technology:Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting 2Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting 3Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting 4Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting 5Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery 2Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery 3
(Date:12/3/2009)...en and his co-workers discovered that specific typ...ncer. Scientists soon found out how these pathogen...t the main culprits are viral proteins E6 and E7. ...l functions, thus promoting cell growth. , Prof...e now discovered another mechanism by which the E6...
(Date:12/3/2009)...ar panels that repels grime and dirt? Expanded bat... New Tel Aviv University research, just published ... in assembling peptides at the nano-scale level th...n just a few years. , Operating in the range of ...and even smaller, graduate student Lihi Adler-Abra...
(Date:12/3/2009)...entists believe that staph infections are caused b...mit toxins. The signaling process is called quorum...start the process. , But the Jeff Brinker resear...of staph infection, when bacteria switch from a ha... and that this individual process can be stopped b...
Breaking Biology News(10 mins):Papillomavirus silences innate immune response 2A window that washes itself? 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3New Precision Radiation Treatment System Fights Cancer 55423 1New Precision Radiation Treatment System Fights Cancer 55423 2New Precision Radiation Treatment System Fights Cancer 55423 3Low Carb Diet Referenced in BIDMC Study Not Related to Atkins 55420 1Low Carb Diet Referenced in BIDMC Study Not Related to Atkins 55420 2Low Carb Diet Referenced in BIDMC Study Not Related to Atkins 55420 3Low Carb Diet Referenced in BIDMC Study Not Related to Atkins 55420 4Low Carb Diet Referenced in BIDMC Study Not Related to Atkins 55420 5The Omics Generation on Facebook 55415 1The Omics Generation on Facebook 55415 2
..., 2008) Two studies published in the current iss...ficacy of transplanting bone marrow cells (BMCs) f...ound that implanting adult cardiomyocytes (heart m...ntages over transplanting cardiomyocytes alone. Fi...nting cardiomyocytes alone, the therapeutic effect...
...d sleep medicine specialists from two Michigan uni... to put innovative quantitative analysis, signal-p...rk in the sleep lab. One of their recent findings...tation appears to distinguish fibromyalgia patient...search scientist and engineer at the Michigan Tech...
...ork, Departmental and Workgroup Scanners Recognize... Equipment SUNNYVALE, Calif., Sept. 2 /PRNewswi... market leader in document imaging scanners and se... earned the "Editor,s Choice",designation in the B...he,Fujitsu fi-6130, fi-6230, fi-6140, fi-6240, fi-...
Other Biology News:Cardiac cell transplant studies show promise in cardiac tissue repair 2What a sleep study can reveal about fibromyalgia 2What a sleep study can reveal about fibromyalgia 3Fujitsu Scanners Selected as 'Editor's Choice' in Better Buys for Business 2008 Scan-to-File Guide 2Fujitsu Scanners Selected as 'Editor's Choice' in Better Buys for Business 2008 Scan-to-File Guide 3
Rabbit Anti-Human Sirtuin (silent mating type information regulation 2, S.cerevisiae, homolog) 7 (SIRT7) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
...te sealer with an integrated in-line plate stacker...configurations and sealing capabilities. ,Featur...240-plate storage capacity , Integrated with Hudso...les all SBS microplates and tube racks , Variety o...
...of mouse embryonic stem cells to dopaminergic neur...here they are mainly located in the substantia nig...l field. These dopaminergic (DA) neurons give rise....projections to the caudate nucleus, putamen nucle...
...mer screening and binding optimization and built o...n-chip synthesis platform. Thousands of customer s...LC Sciences can provide assistance with custom seq...art of our comprehensive DNA/RNA Aptamer Microarra...
Biology Products: